Not Yet RecruitingPhase 1/2

Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Egypt15 participantsStarted 2025-08-30

Plain-language summary

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Who can participate

Age range18 Years – 40 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Androgenetic Alopecia Grades 1-4 Exclusion Criteria: * blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

What they're measuring

Terminal to vellus hair ratio improvement

Timeframe: One year

Trial details

NCT IDNCT07112586

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-31

Contact for this trial

Dana Ashraf Maher, Assistant lecturer

+20 1225077011 dana.maher1@outlook.com

View on ClinicalTrials.gov More Androgenetic Alopecia trials